Last updated: November 28, 2022
Sponsor: University Hospital, Caen
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05640128
17-209
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients (18-75 years old) with moderate to severe hypertension, which justifiescarrying out an etiological assessment in a hospital environment.
- Assessment carried out in compliance with the standardized measurement conditions ofthe RAR defined by the SFE consensus,
- Signature of a written consent by the patient
Exclusion
Exclusion Criteria:
- Patient on antihypertensive treatment other than alpha-blockers, calcium channelblockers or centrally acting antihypertensive
- Etiology of secondary hypertension other than PAH
Study Design
Total Participants: 300
Study Start date:
January 02, 2018
Estimated Completion Date:
January 31, 2024
Connect with a study center
CAEN University Hospital
Caen,
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.